KR100827254B1
(ko)
*
|
1998-06-03 |
2008-05-07 |
알자 코포레이션 |
연장된 약물 치료를 제공하기 위한 방법 및 장치
|
DE69923200T2
(de)
*
|
1998-10-01 |
2005-12-22 |
Novartis Ag |
Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe
|
US8293277B2
(en)
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
EP2266542A3
(en)
*
|
1998-10-01 |
2013-07-31 |
Elan Pharma International Limited |
Controlled release nanoparticulate compositions
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
US8236352B2
(en)
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
US6706283B1
(en)
*
|
1999-02-10 |
2004-03-16 |
Pfizer Inc |
Controlled release by extrusion of solid amorphous dispersions of drugs
|
IL145688A0
(en)
*
|
1999-03-29 |
2002-06-30 |
American Home Prod |
Coating system
|
CN1173695C
(zh)
|
1999-06-14 |
2004-11-03 |
科斯默股份公司 |
控制释放与掩蔽味道的口服药物组合物
|
US8895064B2
(en)
|
1999-06-14 |
2014-11-25 |
Cosmo Technologies Limited |
Controlled release and taste masking oral pharmaceutical composition
|
US20090104273A1
(en)
*
|
1999-06-22 |
2009-04-23 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
US6267986B1
(en)
|
1999-09-24 |
2001-07-31 |
Ranbaxy Laboratories Limited |
Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
|
GB9923045D0
(en)
*
|
1999-09-29 |
1999-12-01 |
Novartis Ag |
New oral formulations
|
US6346231B1
(en)
*
|
1999-10-06 |
2002-02-12 |
Joar Opheim |
Flavored gelatin capsule and method of manufacture
|
BR0007360A
(pt)
*
|
1999-12-23 |
2001-08-14 |
Johnson & Johnson |
Composição de liberação controlada
|
CA2395333C
(en)
*
|
1999-12-23 |
2009-01-13 |
Pfizer Products Inc. |
Hydrogel-driven drug dosage form
|
JP2003518487A
(ja)
|
1999-12-23 |
2003-06-10 |
ファイザー・プロダクツ・インク |
ヒドロゲル駆動型積層薬物製剤
|
KR20020063282A
(ko)
*
|
1999-12-28 |
2002-08-01 |
아지노모토 가부시키가이샤 |
경구 투여용 당뇨병 치료제
|
US6248359B1
(en)
*
|
2000-01-05 |
2001-06-19 |
Laboratorios Phoenix U.S.A., Inc. |
Multi-tablet oxybutynin system for treating incontinence
|
WO2001051039A1
(en)
*
|
2000-01-13 |
2001-07-19 |
Osmotica Corp. |
Osmotic device containing ranitidine and a prokinetic agent
|
US6521255B2
(en)
|
2000-01-13 |
2003-02-18 |
Osmotica Corp. |
Osmotic device containing ranitidine and a prokinetic agent
|
US6569456B2
(en)
|
2000-01-13 |
2003-05-27 |
Osmotica Corp. |
Osmotic device containing diltiazem and an ACE inhibitor or diuretic
|
US6613357B2
(en)
*
|
2000-01-13 |
2003-09-02 |
Osmotica Corp. |
Osmotic device containing pseudoephedrine and an H1 antagonist
|
US6572890B2
(en)
*
|
2000-01-13 |
2003-06-03 |
Osmotica Corp. |
Osmotic device containing venlafaxine and an anti-psychotic agent
|
US7147870B2
(en)
*
|
2000-01-13 |
2006-12-12 |
Osmotica Corp. |
Osmotic device containing pseudoephedrine and an H1 antagonist
|
US6599532B2
(en)
*
|
2000-01-13 |
2003-07-29 |
Osmotica Corp. |
Osmotic device containing alprazolam and an antipsychotic agent
|
US6491949B2
(en)
*
|
2000-01-14 |
2002-12-10 |
Osmotica Corp. |
Osmotic device within an osmotic device
|
AR026148A1
(es)
*
|
2000-01-21 |
2003-01-29 |
Osmotica Argentina S A |
Dispositivo osmotico con pasaje preformado que aumenta de tamano
|
GB0007419D0
(en)
*
|
2000-03-27 |
2000-05-17 |
Smithkline Beecham Gmbh |
Composition
|
US6551617B1
(en)
*
|
2000-04-20 |
2003-04-22 |
Bristol-Myers Squibb Company |
Taste masking coating composition
|
US20040156872A1
(en)
*
|
2000-05-18 |
2004-08-12 |
Elan Pharma International Ltd. |
Novel nimesulide compositions
|
US6770297B1
(en)
*
|
2000-05-26 |
2004-08-03 |
Unitech Pharmaceuticals, Inc. |
Controlled release delivery system of solid dosage form
|
JPWO2002024167A1
(ja)
*
|
2000-09-19 |
2004-01-29 |
第一製薬株式会社 |
医薬組成物
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
EP1334732B1
(en)
*
|
2000-11-17 |
2010-06-02 |
Takeda Pharmaceutical Company Limited |
Pharmaceutical preparation of n-[2-(1,6,7,8-tetrahydro-2h-indeno[5,4 b]furan-8-yl)ethyl]propionamide coated with a copolyvidone-containing coating free of polyethylene glycol
|
CA2434156A1
(en)
|
2000-12-29 |
2002-07-25 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices
|
US20020086051A1
(en)
*
|
2001-01-03 |
2002-07-04 |
Santos Viscasillas |
Sustained release drug delivery devices with coated drug cores
|
US6756058B2
(en)
|
2001-01-03 |
2004-06-29 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with multiple agents
|
EP1349531A1
(en)
*
|
2001-01-12 |
2003-10-08 |
Sun Pharmaceuticals Industries Ltd. |
Spaced drug delivery system
|
EP1240897B1
(en)
*
|
2001-03-14 |
2006-06-21 |
Pfizer Products Inc. |
Pharmaceutical tablet and process for making thereof
|
US20030143272A1
(en)
*
|
2001-03-14 |
2003-07-31 |
Waterman Kenneth C. |
Pharmaceutical tablet and process for making thereof
|
US6951654B2
(en)
*
|
2001-03-27 |
2005-10-04 |
Galen (Chemicals) Limited |
Intravaginal drug delivery devices for the administration of an antimicrobial agent
|
PT1377276E
(pt)
*
|
2001-04-10 |
2011-12-30 |
Sun Pharma Advanced Res Co Ltd |
Composição de libertação temporizada por pulso
|
US6838093B2
(en)
*
|
2001-06-01 |
2005-01-04 |
Shire Laboratories, Inc. |
System for osmotic delivery of pharmaceutically active agents
|
US7938277B2
(en)
|
2001-08-24 |
2011-05-10 |
Dober Chemical Corporation |
Controlled release of microbiocides
|
KR100628603B1
(ko)
*
|
2001-09-03 |
2006-09-26 |
디에스엠 아이피 어셋츠 비.브이. |
펙틴 및 아스코르브산을 포함하는 조성물
|
WO2003026555A2
(en)
*
|
2001-09-25 |
2003-04-03 |
J.B. Chemicals & Pharmaceuticals Ltd. |
Floating osmotic device for controlled release drug delivery
|
CN1564691A
(zh)
*
|
2001-10-08 |
2005-01-12 |
太阳医药工业有限公司 |
一种止痉挛剂的间隔药物释出系统
|
US6635675B2
(en)
|
2001-11-05 |
2003-10-21 |
Cypress Bioscience, Inc. |
Method of treating chronic fatigue syndrome
|
US6602911B2
(en)
|
2001-11-05 |
2003-08-05 |
Cypress Bioscience, Inc. |
Methods of treating fibromyalgia
|
US20030185882A1
(en)
*
|
2001-11-06 |
2003-10-02 |
Vergez Juan A. |
Pharmaceutical compositions containing oxybutynin
|
US8329217B2
(en)
|
2001-11-06 |
2012-12-11 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Dual controlled release dosage form
|
US6863901B2
(en)
*
|
2001-11-30 |
2005-03-08 |
Collegium Pharmaceutical, Inc. |
Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
|
US6827946B2
(en)
*
|
2001-12-05 |
2004-12-07 |
Collegium Pharmaceutical, Inc. |
Compositions containing both sedative and non-sedative antihistamines
|
AU2002357935A1
(en)
*
|
2001-12-18 |
2003-06-30 |
Alza Corporation |
Dosage form for providing time-varying patterns of drug delivery
|
EP1467717A1
(en)
*
|
2002-01-15 |
2004-10-20 |
Ranbaxy Laboratories Limited |
Stable pharmaceutical compositions comprising ace inhibitor(s)
|
KR100540035B1
(ko)
*
|
2002-02-01 |
2005-12-29 |
주식회사 태평양 |
다단계 경구 약물 방출 제어 시스템
|
ATE464880T1
(de)
|
2002-02-04 |
2010-05-15 |
Elan Pharma Int Ltd |
Arzneistoffnanopartikel mit lysozym- oberflächenstabilisator
|
ITMI20020515A1
(it)
*
|
2002-03-12 |
2003-09-12 |
Jagotec Ag |
Sistema per il rilasco controllato di uno o piu' principi attivi
|
ITMI20020514A1
(it)
*
|
2002-03-12 |
2003-09-12 |
Jagotec Ag |
Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
|
WO2003086363A1
(en)
*
|
2002-04-08 |
2003-10-23 |
Lavipharm Laboratories Inc. |
Drug-complex microparticles and methods of making/using same
|
US8956160B2
(en)
*
|
2002-07-02 |
2015-02-17 |
Ranir, Llc |
Device and method for delivering an oral care agent
|
US20040258757A1
(en)
*
|
2002-07-16 |
2004-12-23 |
Elan Pharma International, Ltd. |
Liquid dosage compositions of stable nanoparticulate active agents
|
US20050208132A1
(en)
*
|
2002-07-29 |
2005-09-22 |
Gayatri Sathyan |
Methods and dosage forms for reducing side effects of benzisozazole derivatives
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
KR100456833B1
(ko)
*
|
2002-08-01 |
2004-11-10 |
주식회사 대웅 |
아목시실린 및 클라불라네이트를 함유하는 유핵정
|
CA2497975A1
(en)
*
|
2002-09-09 |
2004-03-18 |
Endo Pharmaceuticals Inc. |
Combined immediate release and extended release analgesic composition
|
US9107804B2
(en)
|
2002-12-10 |
2015-08-18 |
Nortec Development Associates, Inc. |
Method of preparing biologically active formulations
|
MXPA05005812A
(es)
*
|
2002-12-11 |
2005-08-16 |
Pfizer Prod Inc |
Liberacion controlada de una sustancia activa a un entorno rico en grasa.
|
CA2509688A1
(en)
*
|
2002-12-20 |
2004-07-08 |
Pfizer Products Inc. |
Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor
|
US20070077301A1
(en)
*
|
2002-12-23 |
2007-04-05 |
Meyer Glenn A |
Venlafaxine osmotic device formulation
|
US8293799B2
(en)
*
|
2003-12-29 |
2012-10-23 |
Osmotica Keresleedelmo és Szolgáltató KFT |
Osmotic device containing a venlafaxine salt and a salt having an ion in common
|
US7524515B2
(en)
*
|
2003-01-10 |
2009-04-28 |
Mutual Pharmaceuticals, Inc. |
Pharmaceutical safety dosage forms
|
JP2004231520A
(ja)
*
|
2003-01-28 |
2004-08-19 |
Nichiko Pharmaceutical Co Ltd |
保存安定性及び溶出速度に優れた医薬組成物
|
WO2004108067A2
(en)
*
|
2003-04-03 |
2004-12-16 |
Sun Pharmaceutical Industries Limited |
Programmed drug delivery system
|
US20040202693A1
(en)
*
|
2003-04-14 |
2004-10-14 |
Rong-Kun Chang |
Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem
|
US20060177507A1
(en)
*
|
2003-05-22 |
2006-08-10 |
Joaquina Faour |
Controlled release device containing lercanidipine
|
US8029822B2
(en)
*
|
2003-05-22 |
2011-10-04 |
Osmotica Kereskedelmi és Seolgáltató KFT |
Rupturing controlled release device having a preformed passageway
|
KR100473422B1
(ko)
*
|
2003-06-12 |
2005-03-14 |
박원봉 |
렉틴 함유 천연물의 장용성 코팅용 조성물
|
DE10328666A1
(de)
*
|
2003-06-26 |
2005-01-13 |
Bayer Healthcare Ag |
Tabletten enthaltend Geschmacks-und/oder Aromastoffe
|
US20050013869A1
(en)
*
|
2003-07-18 |
2005-01-20 |
Chaw Cheng Shu |
Sustained release formulation for carbamates and a method therefor
|
CN1819821B
(zh)
|
2003-08-08 |
2010-10-13 |
拜奥维尔实验室国际股份有限公司 |
盐酸安非他酮的改良释放片剂
|
US7611728B2
(en)
*
|
2003-09-05 |
2009-11-03 |
Supernus Pharmaceuticals, Inc. |
Osmotic delivery of therapeutic compounds by solubility enhancement
|
WO2005030166A1
(en)
*
|
2003-09-26 |
2005-04-07 |
Alza Corporation |
Oros push-stick for controlled delivery of active agents
|
NZ546148A
(en)
|
2003-09-26 |
2009-05-31 |
Alza Corp |
Drug coating providing high drug loading and methods for providing the same
|
US20070259033A1
(en)
*
|
2003-09-26 |
2007-11-08 |
Evangeline Cruz |
Controlled release formulations exhibiting an ascending rate of release
|
US8709476B2
(en)
|
2003-11-04 |
2014-04-29 |
Supernus Pharmaceuticals, Inc. |
Compositions of quaternary ammonium compounds containing bioavailability enhancers
|
ATE493981T1
(de)
*
|
2003-11-04 |
2011-01-15 |
Supernus Pharmaceuticals Inc |
Einmal tägliche dosierformen von trospium
|
US7387793B2
(en)
|
2003-11-14 |
2008-06-17 |
Eurand, Inc. |
Modified release dosage forms of skeletal muscle relaxants
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
US20050129764A1
(en)
*
|
2003-12-11 |
2005-06-16 |
Vergez Juan A. |
Osmotic device containing licofelone
|
US20050136116A1
(en)
*
|
2003-12-18 |
2005-06-23 |
Keith Whitehead |
Stabilized prednisolone sodium phosphate solutions
|
US7670624B2
(en)
*
|
2004-01-29 |
2010-03-02 |
Astella Pharma Inc. |
Gastrointestinal-specific multiple drug release system
|
DK1566173T3
(da)
*
|
2004-02-20 |
2006-12-27 |
Mattern Udo |
Farmaceutisk sammensætning til oral anvendelse og fremgangsmåde til fremstilling deraf
|
AU2005247195A1
(en)
*
|
2004-05-27 |
2005-12-08 |
Dexcel Pharma Technologies Ltd |
Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins
|
US20050287185A1
(en)
*
|
2004-06-23 |
2005-12-29 |
David Wong |
Extended release oxybutynin formulation
|
US20060008527A1
(en)
*
|
2004-07-09 |
2006-01-12 |
Yury Lagoviyer |
Controlled phase composition technology as an improved process for protection of drugs
|
US8541026B2
(en)
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
US20060099550A1
(en)
*
|
2004-11-10 |
2006-05-11 |
Ranir/Dcp Corporation |
Device and method for delivering an oral care agent
|
AR053986A1
(es)
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
US8252331B2
(en)
*
|
2004-12-03 |
2012-08-28 |
Osmotica Kereskedelmi és Szolgáltató, KFT |
Osmotic device containing amantadine and an osmotic salt
|
US8574626B2
(en)
|
2004-12-03 |
2013-11-05 |
Osmotica Kereskedelmi és Szolgáltató KFT |
Osmotic device containing amantadine and an osmotic salt
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
GB2421431B
(en)
*
|
2004-12-24 |
2007-10-10 |
Aquasol Ltd |
Dosing systems
|
EP1846382A2
(en)
*
|
2005-01-26 |
2007-10-24 |
Elan Pharma International Limited |
Controlled release compositions comprising an antipsychotic agent
|
WO2006085128A1
(en)
*
|
2005-02-09 |
2006-08-17 |
Wockhardt Limited |
Cardiovascular therapeutic combinations
|
US7994220B2
(en)
|
2005-09-28 |
2011-08-09 |
Cypress Bioscience, Inc. |
Milnacipran for the long-term treatment of fibromyalgia syndrome
|
US8440695B2
(en)
*
|
2005-11-09 |
2013-05-14 |
St Jude Children's Research Hospital |
Use of chloroquine to treat metabolic syndrome
|
BRPI0620863A8
(pt)
|
2005-12-29 |
2018-01-16 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
comprimido em camadas com combinação de liberação tripla
|
US20070190141A1
(en)
*
|
2006-02-16 |
2007-08-16 |
Aaron Dely |
Extended release opiate composition
|
WO2008001311A2
(en)
*
|
2006-06-26 |
2008-01-03 |
Ranbaxy Laboratories Limited |
Pharmaceutical composition containing fixed dose combination of atenolol with isosorbide mononitrate
|
WO2008005287A1
(en)
*
|
2006-06-30 |
2008-01-10 |
Teva Pharmaceutical Industries Ltd. |
Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant
|
US8124598B2
(en)
*
|
2006-09-14 |
2012-02-28 |
Sharon Sageman |
7-keto DHEA for psychiatric use
|
US20080085311A1
(en)
*
|
2006-10-05 |
2008-04-10 |
Tripathi Sanjay S |
Antihistamine-decongestant combinations
|
CN100584319C
(zh)
*
|
2006-10-16 |
2010-01-27 |
北京科信必成医药科技发展有限公司 |
群孔释放渗透泵控释片及其制备方法
|
US7731604B2
(en)
*
|
2006-10-31 |
2010-06-08 |
Taylor Made Golf Company, Inc. |
Golf club iron head
|
EP2120945A1
(en)
*
|
2007-02-28 |
2009-11-25 |
Collegium Pharmaceutical, Inc. |
Antihistamine combination
|
US20100143471A1
(en)
*
|
2007-03-21 |
2010-06-10 |
Lupin Limited |
Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine
|
US8404275B2
(en)
|
2007-07-01 |
2013-03-26 |
Vitalis Llc |
Combination tablet with chewable outer layer
|
KR101458774B1
(ko)
*
|
2007-08-15 |
2014-11-07 |
맥네일-피피씨, 인코포레이티드 |
즉시 방출 및 지속 방출 이부프로펜 투약 계획
|
US20100160274A1
(en)
*
|
2007-09-07 |
2010-06-24 |
Sharon Sageman |
7-KETO DHEA for Psychiatric Use
|
US8771643B2
(en)
*
|
2008-01-04 |
2014-07-08 |
Schabar Research Associates Llc |
Use of analgesic potentiating compounds to potentiate the analgesic properties of an analgesic compound
|
JP2009256237A
(ja)
*
|
2008-04-16 |
2009-11-05 |
Daiichi Sankyo Healthcare Co Ltd |
固形製剤
|
US7883638B2
(en)
*
|
2008-05-27 |
2011-02-08 |
Dober Chemical Corporation |
Controlled release cooling additive compositions
|
US8591747B2
(en)
|
2008-05-27 |
2013-11-26 |
Dober Chemical Corp. |
Devices and methods for controlled release of additive compositions
|
US8702995B2
(en)
|
2008-05-27 |
2014-04-22 |
Dober Chemical Corp. |
Controlled release of microbiocides
|
US20090294379A1
(en)
*
|
2008-05-27 |
2009-12-03 |
Dober Chemical Corporation |
Controlled release of additive compositions
|
AU2009279372A1
(en)
|
2008-08-06 |
2010-02-11 |
Gosforth Centre (Holdings) Pty Ltd |
Compositions and methods for treating psychiatric disorders
|
AU2009308885A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Mcneil-Ppc, Inc. |
Osmotic tablet with a compressed outer coating
|
DE102008059206A1
(de)
*
|
2008-11-27 |
2010-06-10 |
Bayer Schering Pharma Aktiengesellschaft |
Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
|
WO2010140111A1
(en)
|
2009-06-02 |
2010-12-09 |
Ranbaxy Laboratories Limited |
Pharmaceutical compositions containing a combination of an antihistamine and a decongestant
|
EP2488029B1
(en)
|
2009-09-30 |
2016-03-23 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse
|
JP5609105B2
(ja)
*
|
2009-12-24 |
2014-10-22 |
ライオン株式会社 |
ラニチジン含有被覆粒子及びその製造方法
|
US20130230586A1
(en)
|
2010-10-02 |
2013-09-05 |
Link Research & Grants Corporation |
Treatment of Tinnitus and Related Auditory Dysfunctions
|
JP6068454B2
(ja)
|
2011-06-06 |
2017-01-25 |
オーク・クレスト・インスティテュート・オブ・サイエンスOak Crest Institute Of Science |
ウィッキング放出ウィンドウを利用した薬剤デリバリーデバイス
|
DE102011051653A1
(de)
*
|
2011-07-07 |
2013-01-10 |
Lts Lohmann Therapie-Systeme Ag |
Quellfähige Manteltablette
|
GB201111712D0
(en)
|
2011-07-08 |
2011-08-24 |
Gosforth Ct Holdings Pty Ltd |
Pharmaceutical compositions
|
US10154964B2
(en)
|
2011-09-07 |
2018-12-18 |
Cosmo Technologies Limited |
Controlled release and taste masking oral pharmaceutical composition
|
JP6210988B2
(ja)
|
2011-09-19 |
2017-10-11 |
オレクソ・アクチエボラゲット |
オピオイド依存を治療するための新規乱用耐性医薬組成物
|
US9381112B1
(en)
|
2011-10-06 |
2016-07-05 |
William Eric Sponsell |
Bleb drainage device, ophthalmological product and methods
|
WO2013063078A1
(en)
|
2011-10-28 |
2013-05-02 |
Vitalis Llc |
Anti-flush compositions
|
US8632489B1
(en)
|
2011-12-22 |
2014-01-21 |
A. Mateen Ahmed |
Implantable medical assembly and methods
|
CN102696587B
(zh)
*
|
2012-06-15 |
2014-03-26 |
河南好年景生物发展有限公司 |
一种复配型控释农药颗粒制剂及制备方法
|
CN104968333B
(zh)
|
2012-11-30 |
2018-07-10 |
阿库拉制药公司 |
活性药物成分的自调节释放
|
WO2014102741A2
(en)
*
|
2012-12-28 |
2014-07-03 |
University Of The Witwatersrand, Johannesburg |
Pharmaceutical dosage form
|
JP6114571B2
(ja)
*
|
2013-01-23 |
2017-04-12 |
高砂熱学工業株式会社 |
流水設備用の抗菌器具
|
WO2015073736A1
(en)
|
2013-11-13 |
2015-05-21 |
Arbor Pharmaceuticals, Llc |
Methods and compositions for treating adhd
|
CA2943728C
(en)
|
2014-03-26 |
2020-03-24 |
Sun Pharma Advanced Research Company Ltd. |
Abuse deterrent immediate release biphasic matrix solid dosage form
|
AU2016288643A1
(en)
|
2015-07-02 |
2018-02-22 |
University Of Louisville Research Foundation, Inc. |
Edible plant-derived microvesicle compositions for delivery of miRNA and methods for treatment of cancer
|
WO2017040607A1
(en)
|
2015-08-31 |
2017-03-09 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for self-regulated release of active pharmaceutical ingredient
|
CA3040531A1
(en)
|
2016-12-20 |
2018-06-28 |
Colgate-Palmolive Company |
Oral care composition
|
RU2735525C1
(ru)
|
2016-12-20 |
2020-11-03 |
Колгейт-Палмолив Компани |
Композиции для ухода за полостью рта
|
CA3040738A1
(en)
|
2016-12-20 |
2018-06-28 |
Colgate-Palmolive Company |
Oral care compositions
|
WO2019023617A1
(en)
*
|
2017-07-27 |
2019-01-31 |
University Of Utah Research Foundation |
DEVICE FOR DELIVERY OF THERAPEUTIC PRODUCT
|
US10213394B1
(en)
|
2018-02-15 |
2019-02-26 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság |
Composition and method for treating neurological disease
|
US20190247331A1
(en)
|
2018-02-15 |
2019-08-15 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság |
Composition and method for treating neurological disease
|
US10213393B1
(en)
|
2018-02-15 |
2019-02-26 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Feleõsségû Társaság |
Composition and method for treating neurological disease
|
US11000471B2
(en)
*
|
2018-03-05 |
2021-05-11 |
Kashiv Specialty Pharmaceuticals, Llc |
Programmable pharmaceutical compositions for chrono drug release
|
JP7502741B2
(ja)
*
|
2019-09-26 |
2024-06-19 |
スピンセンシングファクトリー株式会社 |
磁気マーカーおよび磁気マーカー検出システム
|
JP2022551520A
(ja)
|
2019-10-08 |
2022-12-09 |
バイエル・ヘルスケア・エルエルシー |
レーザエッチングされたカプセルおよびその製造方法
|
WO2021105792A1
(en)
*
|
2019-11-28 |
2021-06-03 |
Caprika Srl |
Rectal-use composition for the treatment of constipation
|
US11324727B2
(en)
|
2020-07-15 |
2022-05-10 |
Schabar Research Associates, Llc |
Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
|
JP2023534810A
(ja)
|
2020-07-15 |
2023-08-14 |
シャバー リサーチ アソシエイツ エルエルシー |
急性痛の処置並びに胸やけの重症度及び/又はリスクの低減のための、イブプロフェン及びファモチジンから構成される単位経口用量組成物
|
CA3216359A1
(en)
|
2021-04-07 |
2022-10-13 |
Battelle Memorial Institute |
Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
|